Castor has announced free access to its clinical trial technology platform for U.S. researchers impacted by recent NIH funding cuts. Through the Castor for Impact Program, investigators can maintain data integrity, streamline workflows, and keep projects moving forward, despite reduced indirect cost allocations threatening vital scientific progress and ongoing discovery.
Innovative Program Offers Discounted or Free Access to Clinical Trial Technology, Empowering Underserved Research Areas and Early-Stage Biotech and Medical Device Companies
The partnership will streamline the synchronization of clinical trial and real-world data throughout the clinical research stages.
The partnership will streamline the synchronization of clinical trial and real-world data throughout the clinical research stages.
The latest report from Industry Standard Research (ISR) Sheds Light on eCOA/ePRO Market Dynamics. The Performance of Castor Shines Through.
Today, Castor announces its collaboration with Microsoft to integrate Practical AI in clinical trials, reducing trial burdens for patients & sites.
His exceptional leadership experience and extensive industry knowledge in the healthcare and technology industries will be invaluable to Castor
Castor, an industry leader in modular, patient-centric, clinical trial technology, today announced the appointment of Jeanne Hecht to its Board of Directors
Castor announces the appointment of Brad Hightower, a leading clinical trials executive, to its advisory board.
